June 14th, 2019 – Xstrahl Medical, global leader in superficial radiotherapy devices to treat non-melanoma skin cancer and dermatological conditions, is spotlighting its RADiant treatment system at the 2019 CalDerm NorCal Conference at the Meritage, Napa Valley, CA....
13th June, 2019 Xstrahl Spotlights Full Range of X-Ray Therapy and Radiation Research Systems at DEGRO 2019, June 13-16th Company also announces launch of patient-focused, German-language website providing information on treatment options for a range of benign...
Radiation exposure is known to cause accelerated aging and damage to the ovary, but the contribution of indirect versus direct effects is not well understood. In their paper “Use of a Small Animal Radiation Research Platform (SARRP) facilitates analysis of systemic...
In the prostate, stem and progenitor cell regenerative capacities have been ascribed to both basal and luminal epithelial cells. Here, we show that a rare subset of mesenchymal cells in the prostate are epithelial-primed Nestin-expressing cells (EPNECs) that can...
Xstrahl is pleased to be invited as a sponsor to the 16th International Tumor Microenvironment Workshop taking place between Thursday 13th June through Saturday 15th June in Miami Beach, Florida. Cancer is a complex and heterogeneous disease involving the interaction...
Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality worldwide and the fastest growing malignancy in the United States. With a 5-year survival rate below 12%, effective therapies for HCC are needed. Current treatments for HCC include microwave...
[vc_row type="in_container" full_screen_row_position="middle" scene_position="center" text_color="dark" text_align="left" overlay_strength="0.3" shape_divider_position="bottom" bg_image_animation="none"][vc_column column_padding="no-extra-padding"...
May 23rd, 2019 Xstrahl Spotlights New RADiant Treatment System at American Society for Mohs Surgery Annual Meetingth Xstrahl Medical, global leader in superficial radiotherapy devices to treat non-melanoma skin cancer and dermatological conditions, is spotlighting...
OBJECTIVES: Hypoxic cancer cells have been shown to be more resistant to radiation therapy than normoxic cells. Hence, this study investigated whether ultrasound (US)-induced rupture of oxygen-carrying microbubbles (MBs) would enhance the response of breast cancer...
Contact Us